Logo image of AHPI

ALLIED HEALTHCARE PRODUCTS (AHPI) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:AHPI - US0192222075 - Common Stock

0.5501 USD
+0.02 (+3.58%)
Last: 2/2/2023, 8:00:00 PM
0.53 USD
-0.02 (-3.65%)
After Hours: 2/2/2023, 8:00:00 PM
Fundamental Rating

1

Overall AHPI gets a fundamental rating of 1 out of 10. We evaluated AHPI against 187 industry peers in the Health Care Equipment & Supplies industry. AHPI has a bad profitability rating. Also its financial health evaluation is rather negative. AHPI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AHPI had negative earnings in the past year.
In the past year AHPI has reported a negative cash flow from operations.
In the past 5 years AHPI reported 4 times negative net income.
In multiple years AHPI reported negative operating cash flow during the last 5 years.
AHPI Yearly Net Income VS EBIT VS OCF VS FCFAHPI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 -2M -4M

1.2 Ratios

The profitability ratios for AHPI are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AHPI Yearly ROA, ROE, ROICAHPI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 -20 -40 -60 -80 -100

1.3 Margins

AHPI has a Gross Margin of 9.34%. This is amonst the worse of the industry: AHPI underperforms 81.94% of its industry peers.
AHPI's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for AHPI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 9.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.28%
GM growth 5Y-13.86%
AHPI Yearly Profit, Operating, Gross MarginsAHPI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 10 -10 20

More info and screens

2

2. Health

2.1 Basic Checks

AHPI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AHPI has about the same amount of shares outstanding.
Compared to 1 year ago, AHPI has a worse debt to assets ratio.
AHPI Yearly Shares OutstandingAHPI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 1M 2M 3M 4M
AHPI Yearly Total Debt VS Total AssetsAHPI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of -0.28, we must say that AHPI is in the distress zone and has some risk of bankruptcy.
AHPI's Altman-Z score of -0.28 is in line compared to the rest of the industry. AHPI outperforms 42.13% of its industry peers.
AHPI has a Debt/Equity ratio of 1.52. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of AHPI (1.52) is worse than 84.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.52
Debt/FCF N/A
Altman-Z -0.28
ROIC/WACCN/A
WACC5.72%
AHPI Yearly LT Debt VS Equity VS FCFAHPI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 5M 10M 15M 20M

2.3 Liquidity

A Current Ratio of 2.69 indicates that AHPI has no problem at all paying its short term obligations.
AHPI has a worse Current ratio (2.69) than 64.35% of its industry peers.
A Quick Ratio of 1.27 indicates that AHPI should not have too much problems paying its short term obligations.
AHPI has a worse Quick ratio (1.27) than 77.78% of its industry peers.
Industry RankSector Rank
Current Ratio 2.69
Quick Ratio 1.27
AHPI Yearly Current Assets VS Current LiabilitesAHPI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M

More info and screens

0

3. Growth

3.1 Past

AHPI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -420.62%.
The Revenue for AHPI has decreased by -25.45% in the past year. This is quite bad
Measured over the past years, AHPI shows a decrease in Revenue. The Revenue has been decreasing by -4.19% on average per year.
EPS 1Y (TTM)-420.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-226.18%
Revenue 1Y (TTM)-25.45%
Revenue growth 3Y-4.85%
Revenue growth 5Y-4.19%
Sales Q2Q%-14.32%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AHPI Yearly Revenue VS EstimatesAHPI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

AHPI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AHPI Price Earnings VS Forward Price EarningsAHPI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AHPI Per share dataAHPI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AHPI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALLIED HEALTHCARE PRODUCTS

NASDAQ:AHPI (2/2/2023, 8:00:00 PM)

After market: 0.53 -0.02 (-3.65%)

0.5501

+0.02 (+3.58%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)02-13 2023-02-13/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners2.27%
Ins Owner Change0%
Market Cap2.21M
Revenue(TTM)27.05M
Net Income(TTM)-5.36M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.08
P/FCF N/A
P/OCF N/A
P/B 0.42
P/tB 0.42
EV/EBITDA N/A
EPS(TTM)-1.34
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.04
FCFYN/A
OCF(TTM)-1.02
OCFYN/A
SpS6.74
BVpS1.3
TBVpS1.3
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 9.34%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.28%
GM growth 5Y-13.86%
F-Score2
Asset Turnover1.37
Health
Industry RankSector Rank
Debt/Equity 1.52
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 16.63%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.69
Quick Ratio 1.27
Altman-Z -0.28
F-Score2
WACC5.72%
ROIC/WACCN/A
Cap/Depr(3y)48.49%
Cap/Depr(5y)29.1%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-420.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-226.18%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-25.45%
Revenue growth 3Y-4.85%
Revenue growth 5Y-4.19%
Sales Q2Q%-14.32%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-757.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-8.25%
OCF growth 3YN/A
OCF growth 5YN/A

ALLIED HEALTHCARE PRODUCTS / AHPI FAQ

What is the fundamental rating for AHPI stock?

ChartMill assigns a fundamental rating of 1 / 10 to AHPI.


Can you provide the valuation status for ALLIED HEALTHCARE PRODUCTS?

ChartMill assigns a valuation rating of 3 / 10 to ALLIED HEALTHCARE PRODUCTS (AHPI). This can be considered as Overvalued.


How profitable is ALLIED HEALTHCARE PRODUCTS (AHPI) stock?

ALLIED HEALTHCARE PRODUCTS (AHPI) has a profitability rating of 0 / 10.